Patent Yard Sign in
Expired Canadian patentCanada

Catheters for treating prostate disease

CA 2106680 C · Owner: Sterzer, Fred · Inventors: Sterzer, Fred

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Applying squeezing pressure to a diseased prostate by means of a urethral , and/or rectal catheter (100) incorporating an inflatable prostate balloon (122); to compress the prostate while it is being irradiated from a microwave antenna (116) increases, the therapeutic temperature to which the prostate tissue more distal to the microwave antenna (116) can be heated without heating any non-prostate tissue beyond a maximum safe temperature and reduces the , temperature differential between the heated more distal and more proximate prostate tissue from the microwave antenna (116).

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed April 12, 1991 and granted July 31, 2001. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 12, 2011.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 12, 2013.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledApril 12, 1991
GrantedJuly 31, 2001
Term endedApril 12, 2011
Patent numberCA 2106680 C
Classification (IPC)A61N5/02 +2 more

Timeline

Timeline From CIPO dates

1992199419961998200020022004200620082010Application filedApril 12, 1991Patent grantedJuly 31, 2001Term endedApril 12, 2011

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.